Beam Therapeutics Inc. · NASDAQ:BEAM
Evans John M. sold 50,000 Beam Therapeutics Inc. shares (Form 4)
Traded Jun 29 to Jun 30, 2026 · Filed Jul 1, 2026
From Jun 29 to Jun 30, 2026, Evans John M. (Director, CEO) sold 50,000 Beam Therapeutics Inc. shares at an average US$34.90 for US$1.74M under a trading plan, leaving 1,047,205 shares. Filed Jul 1, 2026 (Form 4).
- Sold
- 50,000 shares
- Price
- US$34.90 average (US$34.26 to US$35.91)
- Value
- US$1.74M
- Holding after
- 1,047,205 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 29, 2026 | Common Stock | Option exercise | 18,663 | US$0.67 | 1,065,868 | Direct |
| Jun 29, 2026 | Common Stock | Option exercise | 6,337 | US$1.03 | 1,072,205 | Direct |
| Jun 29, 2026 | Common Stock | Sale | 13,421 | US$35.13 | 1,058,784 | Direct |
| Jun 29, 2026 | Common Stock | Sale | 11,579 | US$35.91 | 1,047,205 | Direct |
| Jun 30, 2026 | Common Stock | Option exercise | 25,000 | US$1.03 | 1,072,205 | Direct |
| Jun 30, 2026 | Common Stock | Sale | 23,100 | US$34.26 | 1,049,105 | Direct |
| Jun 30, 2026 | Common Stock | Sale | 1,900 | US$34.84 | 1,047,205 | Direct |
Source
Related
- Beam Therapeutics Inc.
- Evans John M.
- Beam Therapeutics Inc. shareholders
- Form 4 · Evans John M. · Oct 16, 2026
- Form 4 · Evans John M. · Apr 6, 2026
- Form 4 · Evans John M. · Apr 1, 2026
- Form 4 · Cavanagh Bethany J · Oct 2, 2026
- Form 4 · Ciaramella Giuseppe · Sep 25, 2026
- Schedule 13G/A · ARK Investment Management LLC · Aug 14, 2026
- Schedule 13G/A · Farallon Capital Management, L.L.C. · Aug 13, 2026
- Form 4 · Simon Amy · Jul 29, 2026